“…If the existing vaccines are not useful in optimizing vaccination strategies, it would also worth developing autogenous vaccines (inactivated) using characterized unique IBV isolates prevalent in a given geographical area in order to include in the existing vaccination regimes. Given the available scientific evidence against IB vaccination at the hatchery [ 106 , 110 ], it may also be appropriate to postpone the first IB vaccination to a barn vaccination done at seven days of age relying on maternal antibody response to protect the chickens during the first week of life [ 110 ]. There are numerous issues surrounding the use of live attenuated IB vaccines [ 11 , 99 , 119 , 120 , 121 , 122 , 123 , 124 , 125 , 126 ], and relying on inactivated vaccines can be an option, but they inherently lack the ability to induce mucosal immune response, which is critical for the control of IB [ 131 , 132 , 133 ].…”